
Vascular Neurology Fellow @UofUHealth @UofUNeurology 🧠 🏥 🏔️ || #Stroke #VascularNeurology @StrokeAHA_ASA @AHAScience
Salt Lake City, UT
Joined November 2023
- Tweets46
- Following84
- Followers94
- Likes83
🚨 Big news in stroke prevention!
The FDA has approved asundexian, the first Factor XIa inhibitor, for secondary prevention after non-cardioembolic stroke or high-risk TIA.
OCEANIC-STROKE: 26% reduction in ischemic stroke with similar overall major bleeding rates. Presented at ISC 2026 @StrokeAHA_ASA @FDA @UofUNeurology
An exciting new era for stroke prevention! 🧠 🏥 #stroke #neurology
fda.gov/news-events/press-an…
Lifestyle changes we can all make every day to reduce stroke risk and improve brain health. Small steps can make a big difference! 🧠 🏥 || #Stroke #WorldStrokeDay @StrokeAHA_ASA @UofUNeurology @UofUHealth
Beyond Medications: This #WorldStrokeDay, #BloggingStroke contributor @AlexVorobyevMD highlights lifestyle changes that reduce #stroke risk. ahajournals.org/do/10.1161/b…
How much and what kind of physical therapy should patients receive after stroke? Our Phase II trial was just published! 🏥 🧠 ovid.com/jnls/jacpt/fulltext…
Early inpatient physical therapy after acute stroke was associated with meaningful functional improvement. The combination of frequent therapy and error-augmentation produced the greatest gains and superior postural control at discharge #Neurology #Stroke #PhysicalTherapy #Rehabilitation
Assessment of dizziness with and without video head impulse testing (vHIT) in stroke patients as phase I of our study 🧠 🔥 #Neurology #Stroke @AANmember // neurology.org/doi/10.1212/CP…
Officially joining @UofUHealth. Exited about my last step of training in this great place 🏥 || #neurology #stroke
Class of 2026, Neurology, Medical University Of South Carolina #Neurology #Residency 💯✅
🤖 Made with AI
2
392
Neurology Research Day at #MUSC || @MUSChealth from space with Dan Barbosa, MD to MTs with @AbuQdaisA 🔥
#AAN #Neurology #2026 Great time with great people 🧠🔥
144
🚨 #ISC26 delivered BIG for stroke care. Multiple practice-important and promising trials across thrombosis, reperfusion, EVT, ICH, and neuroprotection 🏥🧠👇
🔹 OCEANIC-STROKE – Positive phase III: FXIa inhibition with asundexian reduced ischemic stroke in patients with non-cardioembolic stroke or high-risk TIA on antiplatelet therapy without increased major bleeding
🔹 OPTION – In patients with salvageable tissue, tenecteplase (4.5–24h) significantly improved 90-day excellent outcomes with higher sICH (2.8% vs 0%)
🔹 CHOICE-2 – Largest phase III trial of IA alteplase after successful EVT: higher excellent outcomes (mRS 0–1), no increase in sICH, NNT ≈ 7
🔹 FASTEST – rFVIIa for spontaneous ICH: promising early results in spot sign–positive patients treated <90 min
🔹 LAIS – Loberamisal (dual-target neuroprotection) within 48h for AIS (NIHSS 7–20): 13% absolute increase in excellent functional outcomes at 90 days
🔹 DISTALS – Tigertriever for distal occlusions: higher successful reperfusion at 24h without increased sICH
🔹 ORIENTA-MeVO – EVT for MeVO improved 90-day functional outcomes without excess sICH in a Chinese population
The stroke playbook is evolving in real time. 🔥
#Stroke #ISC26 #VascularNeurology #EVT #Tenecteplase #ICH #ClinicalTrials #AHAScience #StrokeResearch @StrokeAHA_ASA @AHAScience 🧠
Excited to kick off #ISC26 with @AHAScience — a week of cutting-edge stroke science 🧠 #MUSC #Stroke #ISC #Neurology
2
662
2026 AHA/ASA Acute Ischemic Stroke Guidelines are LIVE! 🧠🏥 IVT now officially supported with unknown LKW and 9-hour window. A game-changer for stroke care protocols! #AHA #ASA #Stroke
ahajournals.org/doi/10.1161/…
2
218
Published — even in 2025, vasculitis keeps challenging us at every step: from diagnosis to treatment 🧠 🏥 neurology.org/doi/10.1212/WN…
2025 AHA Guidelines – Key Updates in Vascular Neurology 🧠📑
🔹 After successful EVT for LVO: lowering SBP <140 in the first 24–72h may worsen long-term outcomes (Class III: Harm).
🔹 Acute spontaneous ICH w/ SBP >220: avoid reducing below 130 (Class III: Harm).
🔹 Acute ICH w/ SBP 150–220: target 130–140 for at least 7 days to improve functional outcomes (Class IIA)
#Stroke #VascularNeurology #AHA2025
Just out: The transition of the MUSC system to TNK with comparable safety and functional outcomes. Thanks to the great MUSC team @MarinaBuciuc @samialkasab and my mentor @GhadaMohamedMD || 🏥🧠 strokejournal.org/article/S1…
Excellent results with new clinical trials over the last three years indicate that there is no longer a need to delay anticoagulation for 1–2 weeks 🧠🏥 || #Stroke #VascularNeurology #Afib #Neurology linkedin.com/posts/alexvorob…
4
256
























